T13	Treatment 5 15;26 37	raloxifene alendronate
T16	Sub-Disorder 207 219	osteoporosis
T17	Subject 181 219	postmenopausal women with osteoporosis
T19	Treat-Disorder 70 89;100 120;141 177	vertebral fractures bone mineral density biochemical markers of bone turnover
T15	Drug 5 15	raloxifene
T18	Drug 26 37	alendronate
